戻る Agenda
Session 2b. RA Parallel Session : OPTIMIZING REGULATORY ECOSYSTEM through Innovation, Collaboration & Convergence
Session Chair(s)
Sandy Chan
Associate Director, Regulatory Policy & Intelligence Lead- Asia Pacific
Johnson & Johnson, Singapore
Helene Sou, MSc, RAC
Global Regulatory Policy and Innovation
Takeda Pharmaceutical Company Limited., Singapore
Speaker(s)
Helene Sou, MSc, RAC
Takeda Pharmaceutical Company Limited., Singapore
Global Regulatory Policy and Innovation
Stephanie Chen
MERCK AND CO INC, Singapore
Associate Director, Regulatory Policy APAC
Susanne Ausborn, PhD
Roche, Switzerland
Global Head International Regulatory Policy
Noraisyah binti Mohd Sani
NPRA, Ministry of Health Malaysia, Malaysia
Head, New Drug Product Section
Yee Hoo Looi, PhD
Therapeutic Products Branch, HSA, Singapore
Deputy Director
PREEYAPHON PUTTIJUGLUKSA
Thai FDA , Thailand
New Drug and Investigational Drug, Medicines Regulation Division
Hyang Won Min, MSc, RPh
Johnson & Johnson, Singapore
Vice President, Head of APAC Regulatory Affairs
Wipada Rodtanaporn
Pfizer (thailand) Co., Ltd., Thailand
Head of Regulatory Sciences
Somprasong Preuttanuparp
AstraZeneca (Thailand) Ltd., Thailand
Head of Regulatory Affairs - Thailand and Frontier Markets
Stephanie, Hui Min Ong
SANOFI-AVENTIS SINGAPORE PTE. LTD., Malaysia
Head of Regulatory
Anna Litsiou, PhD, MBA, MSc
AstraZeneca, United Kingdom
Regulatory Policy & Intelligence Director
Elaine Blair, PhD
PTC Therapeutics, Australia
Senior Director, Regulatory Affairs APAC